<DOC>
	<DOC>NCT00294320</DOC>
	<brief_summary>The purpose of this study is to evaluate the performance of two techniques to monitor the clearance of AK lesions when treated with Aldara 5% cream.</brief_summary>
	<brief_title>Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions</brief_title>
	<detailed_description>Each technique will be assessed by comparison of lesion counts (clinical and sub-clinical) revealed by the techniques, at start and end of the study and those demonstrated during treatment. In addition a qualitative assessment of each technique will be made for performance and ease of use.</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>At least 5 clinically typical, visible, discrete, nonhyperkeratotic, nonhypertrophic AK lesions Free of any significant findings (e.g tattoos) in the potential application site area. Willing to discontinue suntanning and use of sunbed/sun parlour use Willing to stop use of moisturisers, body oils, and over the counter retinol products or products containing alpha or beta hydroxyacids in the treatment or surrounding area. Willing ot withhold sunscreen and/or moisturiser use for 24 hours prior to each clinical assessment Evidence of unstable or uncontrolled clinically significant medical condition. Any dermatological disease and or condition in the treatment of the surrounding area that may be exacerbated by treatment with imiquimod. Currently participating in another clinical study or have completed another study within an investigational drug within the past 30 days. Have active chemical dependency or alcoholism Have know allergies to any excipient or study cream Have received previous treatment with imiquimod for any indication within the treatment area. Known to be affected by porphyria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Aldara</keyword>
	<keyword>Actinic Keratosis</keyword>
</DOC>